Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Reproducibility of Heart Rate Variability Revealed by Repeated Measurements during and after Hemodialysis.

Deussing K, Wendt R, Burger R, Gollasch M, Beige J.

Blood Purif. 2019 Dec 6:1-8. doi: 10.1159/000504525. [Epub ahead of print]

PMID:
31812967
2.

Inflammatory leucocyte infiltrates are associated with recovery in biopsy-proven acute interstitial nephritis: a 20-year registry-based case series.

Wendt R, Schliecker J, Beige J.

Clin Kidney J. 2019 Aug 3;12(6):814-820. doi: 10.1093/ckj/sfz097. eCollection 2019 Dec.

3.

Efficacy of Electrical Baroreflex Activation Is Independent of Peripheral Chemoreceptor Modulation.

Heusser K, Thöne A, Lipp A, Menne J, Beige J, Reuter H, Hoffmann F, Halbach M, Eckert S, Wallbach M, Koziolek M, Haarmann H, Joyner MJ, Paton JFR, Diedrich A, Haller H, Jordan J, Tank J.

Hypertension. 2020 Jan;75(1):257-264. doi: 10.1161/HYPERTENSIONAHA.119.13925. Epub 2019 Dec 2.

PMID:
31786986
4.

Early Rapid Decline in Kidney Function as a Beneficial Sign After Starting Antihypertensive Medication.

Beige J.

J Am Heart Assoc. 2019 Jun 4;8(11):e013145. doi: 10.1161/JAHA.119.013145. Epub 2019 Jun 1.

5.

Immunological Alterations due to Hemodialysis Might Interfere with Early Complications in Renal Transplantation.

Mai K, Boldt A, Hau HM, Kirschfink M, Schiekofer S, Keller F, Beige J, Giannis A, Sack U, Rasche FM.

Anal Cell Pathol (Amst). 2019 Mar 25;2019:8389765. doi: 10.1155/2019/8389765. eCollection 2019.

6.

All Gone Down? Emergency Blister Pack Removal.

Beige J, Wallstabe I, Schiefke I.

Dtsch Arztebl Int. 2019 Mar 1;116(9):148. doi: 10.3238/arztebl.2019.0148a. No abstract available.

7.

Kidney protective effects of baroreflex activation therapy in patients with resistant hypertension.

Wallbach M, Zürbig P, Dihazi H, Müller GA, Wachter R, Beige J, Koziolek MJ, Mischak H.

J Clin Hypertens (Greenwich). 2018 Oct;20(10):1519-1526. doi: 10.1111/jch.13365. Epub 2018 Sep 10.

8.

Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes.

Tofte N, Lindhardt M, Adamova K, Beige J, Beulens JWJ, Birkenfeld AL, Currie G, Delles C, Dimos I, Francová L, Frimodt-Møller M, Girman P, Göke R, Havrdova T, Kooy A, Mischak H, Navis G, Nijpels G, Noutsou M, Ortiz A, Parvanova A, Persson F, Ruggenenti PL, Rutters F, Rychlík I, Spasovski G, Speeckaert M, Trillini M, von der Leyen H, Rossing P.

Diabet Med. 2018 Oct;35(10):1375-1382. doi: 10.1111/dme.13669. Epub 2018 Jun 6.

PMID:
29781558
9.

The Pituitary-Thyroid Axis and Prolactin Secretion in Hemodialysis Patients in Two Endemic Regions of Eastern Germany.

Rasche FM, Rettig R, Frese T, Rasche WG, Barinka F, Roesl G, Keller F, Lindner TH, Schneider JG, Beige J, Ebert T, Schiekofer S.

Exp Clin Endocrinol Diabetes. 2018 Jun;126(6):349-356. doi: 10.1055/s-0043-123184. Epub 2018 Feb 23.

PMID:
29475205
10.

Endemic influences of political regimes, healthcare systems, and preferences on the frequencies and incidences of nephropathies in eastern Saxony, Germany
.

Sedaghat S, Heshmati ES, Frese T, Rasche WG, Barinka F, Fahr F, Beige J, Schiekofer S, Rasche FM.

Clin Nephrol. 2017 Dec;88(12):317-327. doi: 10.5414/CN109229.

PMID:
29115212
11.

[Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017].

Koziolek M, Beige J, Wallbach M, Zenker D, Henning G, Halbach M, Mader N, Mahfoud F, Schlieper G, Schwenger V, Hausberg M, Börgel J, Lodde M, van der Giet M, Müller-Ehmsen J, Passauer J, Parmentier S, Lüders S, Krämer BK, Büttner S, Limbourg F, Jordan J, Vonend O, Predel HG, Reuter H.

Internist (Berl). 2017 Oct;58(10):1114-1123. doi: 10.1007/s00108-017-0308-y. German.

PMID:
28835975
12.

Effect of UMOD genotype on long-term graft survival after kidney transplantation in patients treated with cyclosporine-based therapy.

Abdel-Hady Algharably E, Beige J, Kreutz R, Bolbrinker J.

Pharmacogenomics J. 2018 Apr;18(2):227-231. doi: 10.1038/tpj.2017.14. Epub 2017 Apr 18.

PMID:
28418009
13.

FSTL3 is increased in renal dysfunction.

Kralisch S, Hoffmann A, Klöting N, Bachmann A, Kratzsch J, Stolzenburg JU, Dietel A, Beige J, Anders M, Bast I, Blüher M, Zhang MZ, Harris RC, Stumvoll M, Fasshauer M, Ebert T.

Nephrol Dial Transplant. 2017 Oct 1;32(10):1637-1644. doi: 10.1093/ndt/gfw472.

PMID:
28339962
14.

Blood pressure after blinded, randomized withdrawal, and resumption of baroreceptor-activating therapy.

Beige J, Jentzsch T, Wendt R, Hennig G, Koziolek M, Wallbach M.

J Hypertens. 2017 Jul;35(7):1496-1501. doi: 10.1097/HJH.0000000000001339.

PMID:
28267039
15.

An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems.

Wachter R, Halbach M, Bakris GL, Bisognano JD, Haller H, Beige J, Kroon AA, Nadim MK, Lovett EG, Schafer JE, de Leeuw PW.

J Am Soc Hypertens. 2017 Feb;11(2):81-91. doi: 10.1016/j.jash.2016.12.003. Epub 2016 Dec 16.

16.

Limited Accuracy of Colour Doppler Ultrasound Dynamic Tissue Perfusion Measurement in Diabetic Adults.

Stoperka F, Karger C, Beige J.

PLoS One. 2016 Dec 29;11(12):e0168905. doi: 10.1371/journal.pone.0168905. eCollection 2016.

17.

Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis.

Siwy J, Zürbig P, Argiles A, Beige J, Haubitz M, Jankowski J, Julian BA, Linde PG, Marx D, Mischak H, Mullen W, Novak J, Ortiz A, Persson F, Pontillo C, Rossing P, Rupprecht H, Schanstra JP, Vlahou A, Vanholder R.

Nephrol Dial Transplant. 2017 Dec 1;32(12):2079-2089. doi: 10.1093/ndt/gfw337.

18.

Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial.

Lindhardt M, Persson F, Currie G, Pontillo C, Beige J, Delles C, von der Leyen H, Mischak H, Navis G, Noutsou M, Ortiz A, Ruggenenti PL, Rychlik I, Spasovski G, Rossing P.

BMJ Open. 2016 Mar 2;6(3):e010310. doi: 10.1136/bmjopen-2015-010310.

19.

Acute Response to Unilateral Unipolar Electrical Carotid Sinus Stimulation in Patients With Resistant Arterial Hypertension.

Heusser K, Tank J, Brinkmann J, Menne J, Kaufeld J, Linnenweber-Held S, Beige J, Wilhelmi M, Diedrich A, Haller H, Jordan J.

Hypertension. 2016 Mar;67(3):585-91. doi: 10.1161/HYPERTENSIONAHA.115.06486. Epub 2016 Feb 1.

20.

Reconstructive kidney surgery for organ-preserving therapy of renal tumors.

Hamza A, Günther M, Behrendt W, Tietze S, Beige J.

GMS Interdiscip Plast Reconstr Surg DGPW. 2015 Nov 16;4:Doc10. doi: 10.3205/iprs000069. eCollection 2015.

21.

Baroreflex activation therapy in patients with end-stage renal failure: proof of concept.

Beige J, Koziolek MJ, Hennig G, Hamza A, Wendt R, Müller GA, Wallbach M.

J Hypertens. 2015 Nov;33(11):2344-9. doi: 10.1097/HJH.0000000000000697.

PMID:
26335429
22.

CC Chemokine Ligand 18 in ANCA-Associated Crescentic GN.

Brix SR, Stege G, Disteldorf E, Hoxha E, Krebs C, Krohn S, Otto B, Klätschke K, Herden E, Heymann F, Lira SA, Tacke F, Wolf G, Busch M, Jabs WJ, Özcan F, Keller F, Beige J, Wagner K, Helmchen U, Noriega M, Wiech T, Panzer U, Stahl RA.

J Am Soc Nephrol. 2015 Sep;26(9):2105-17. doi: 10.1681/ASN.2014040407. Epub 2015 Mar 11.

23.

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.

Schanstra JP, Zürbig P, Alkhalaf A, Argiles A, Bakker SJ, Beige J, Bilo HJ, Chatzikyrkou C, Dakna M, Dawson J, Delles C, Haller H, Haubitz M, Husi H, Jankowski J, Jerums G, Kleefstra N, Kuznetsova T, Maahs DM, Menne J, Mullen W, Ortiz A, Persson F, Rossing P, Ruggenenti P, Rychlik I, Serra AL, Siwy J, Snell-Bergeon J, Spasovski G, Staessen JA, Vlahou A, Mischak H, Vanholder R.

J Am Soc Nephrol. 2015 Aug;26(8):1999-2010. doi: 10.1681/ASN.2014050423. Epub 2015 Jan 14.

24.

Circulating adipocyte fatty acid binding protein is increased in chronic and acute renal dysfunction.

Ebert T, Hopf LM, Wurst U, Bachmann A, Kralisch S, Lössner U, Platz M, Kratzsch J, Stolzenburg JU, Dietel A, Grisk O, Beige J, Anders M, Bast I, Klöting N, Blüher M, Stumvoll M, Fasshauer M.

Nutr Metab Cardiovasc Dis. 2014 Sep;24(9):1027-34. doi: 10.1016/j.numecd.2014.03.006. Epub 2014 Apr 2.

PMID:
24813306
25.

Limited acute influences of electrical baroreceptor activation on insulin sensitivity and glucose delivery: a randomized, double-blind, crossover clinical study.

May M, Ahrens J, Menne J, Haller H, Beige J, Eckert S, Jordan J, Engeli S.

Diabetes. 2014 Aug;63(8):2833-7. doi: 10.2337/db13-1651. Epub 2014 Mar 19.

26.

Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction.

Hindricks J, Ebert T, Bachmann A, Kralisch S, Lössner U, Kratzsch J, Stolzenburg JU, Dietel A, Beige J, Anders M, Bast I, Blüher M, Stumvoll M, Fasshauer M.

Clin Endocrinol (Oxf). 2014 Jun;80(6):918-24. doi: 10.1111/cen.12380. Epub 2014 Jan 12.

PMID:
24612017
27.

Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.

Siwy J, Schanstra JP, Argiles A, Bakker SJ, Beige J, Boucek P, Brand K, Delles C, Duranton F, Fernandez-Fernandez B, Jankowski ML, Al Khatib M, Kunt T, Lajer M, Lichtinghagen R, Lindhardt M, Maahs DM, Mischak H, Mullen W, Navis G, Noutsou M, Ortiz A, Persson F, Petrie JR, Roob JM, Rossing P, Ruggenenti P, Rychlik I, Serra AL, Snell-Bergeon J, Spasovski G, Stojceva-Taneva O, Trillini M, von der Leyen H, Winklhofer-Roob BM, Zürbig P, Jankowski J.

Nephrol Dial Transplant. 2014 Aug;29(8):1563-70. doi: 10.1093/ndt/gfu039. Epub 2014 Mar 2.

28.

Association of serum alkaline phosphatase with mortality in non-selected European patients with CKD5D: an observational, three-centre survival analysis.

Beige J, Wendt R, Girndt M, Queck KH, Fiedler R, Jehle P.

BMJ Open. 2014 Feb 27;4(2):e004275. doi: 10.1136/bmjopen-2013-004275.

29.

Serum levels of the myokine irisin in relation to metabolic and renal function.

Ebert T, Focke D, Petroff D, Wurst U, Richter J, Bachmann A, Lössner U, Kralisch S, Kratzsch J, Beige J, Bast I, Anders M, Blüher M, Stumvoll M, Fasshauer M.

Eur J Endocrinol. 2014 Mar 8;170(4):501-6. doi: 10.1530/EJE-13-1053. Print 2014 Apr.

PMID:
24399249
30.

Cost-effectiveness of Barostim therapy for the treatment of resistant hypertension in European settings.

Borisenko O, Beige J, Lovett EG, Hoppe UC, Bjessmo S.

J Hypertens. 2014 Mar;32(3):681-92. doi: 10.1097/HJH.0000000000000071.

PMID:
24378998
31.

Dialysis-associated hypertension treated with Telmisartan--DiaTel: a pilot, placebo-controlled, cross-over, randomized trial.

Huber M, Treutler T, Martus P, Kurzidim A, Kreutz R, Beige J.

PLoS One. 2013 Nov 18;8(11):e79322. doi: 10.1371/journal.pone.0079322. eCollection 2013.

32.

Monitoring the Activation of the Sympathetic Nervous System to Improve Hemodialysis Processes.

Kammel R, Beige J, Czygan M, Birnbaum K, Gleisberg O, Pretschner A, Neumuth T.

Biomed Tech (Berl). 2013 Aug;58 Suppl 1. pii: /j/bmte.2013.58.issue-s1-I/bmt-2013-4225/bmt-2013-4225.xml. doi: 10.1515/bmt-2013-4225. Epub 2013 Sep 7. No abstract available.

PMID:
24042867
33.

Staphylococcus colonization, mortality and morbidity in hemodialysis patients: 10 years of observation.

Grünewald T, Lindner M, Weiß S, Ruf I, Treutler T, Ruf B, Beige J.

Int J Hyg Environ Health. 2013 Nov;216(6):751-4. doi: 10.1016/j.ijheh.2013.02.005. Epub 2013 Mar 7.

PMID:
23517737
34.

Serum levels of the adipokine progranulin depend on renal function.

Richter J, Focke D, Ebert T, Kovacs P, Bachmann A, Lössner U, Kralisch S, Kratzsch J, Beige J, Anders M, Bast I, Blüher M, Stumvoll M, Fasshauer M.

Diabetes Care. 2013 Feb;36(2):410-4. doi: 10.2337/dc12-0220. Epub 2012 Oct 1.

35.
36.

Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial.

Hoppe UC, Brandt MC, Wachter R, Beige J, Rump LC, Kroon AA, Cates AW, Lovett EG, Haller H.

J Am Soc Hypertens. 2012 Jul-Aug;6(4):270-6. doi: 10.1016/j.jash.2012.04.004. Epub 2012 Jun 12.

PMID:
22694986
37.

Biased reasoning.

Beige J.

Dtsch Arztebl Int. 2012 Apr;109(17):312-3; author reply 313-4. doi: 10.3238/arztebl.2012.0312b. Epub 2012 Apr 27. No abstract available.

38.

Renal IL-17 expression in human ANCA-associated glomerulonephritis.

Velden J, Paust HJ, Hoxha E, Turner JE, Steinmetz OM, Wolf G, Jabs WJ, Özcan F, Beige J, Heering PJ, Schröder S, Kneißler U, Disteldorf E, Mittrücker HW, Stahl RA, Helmchen U, Panzer U.

Am J Physiol Renal Physiol. 2012 Jun 15;302(12):F1663-73. doi: 10.1152/ajprenal.00683.2011. Epub 2012 Mar 21.

39.

Lack of evidence for systemic cytomegalovirus reactivation in maintenance hemodialysis patients.

Pliquett RU, Klein C, Grünewald T, Ruf BR, Beige J.

Eur J Clin Microbiol Infect Dis. 2011 Dec;30(12):1557-60. doi: 10.1007/s10096-011-1260-8. Epub 2011 Apr 26.

PMID:
21516515
40.

Role of CYP2C9 genetic variants for salt sensitivity and the regulation of the renin-angiotensin-aldosterone system in normotensive men.

Bolbrinker J, Beige J, Huber M, Sharma AM, Thomas A, Deter HC, Kreutz R.

J Hypertens. 2011 Jan;29(1):56-61. doi: 10.1097/HJH.0b013e32833f5de5.

PMID:
20852447
41.

Conservative treatment of the uremic syndrome.

Vanholder R, Argilés A, Beige J, Brunet P, Drüeke TB, Fliser D, Herget-Rosenthal S, Hörl WH, Jörres A, Perna A, Rodriguez-Portillo M, Spasovski G, Stegmayr B, Stenvinkel P, Wanner C, Wiecek A, Massy ZA.

Semin Dial. 2009 Jul-Aug;22(4):449-53. doi: 10.1111/j.1525-139X.2009.00600.x. Review.

PMID:
19709000
42.

The role of EUTox in uremic toxin research.

Vanholder R, Abou-Deif O, Argiles A, Baurmeister U, Beige J, Brouckaert P, Brunet P, Cohen G, De Deyn PP, Drüeke TB, Fliser D, Glorieux G, Herget-Rosenthal S, Hörl WH, Jankowski J, Jörres A, Massy ZA, Mischak H, Perna AF, Rodriguez-Portillo JM, Spasovski G, Stegmayr BG, Stenvinkel P, Thornalley PJ, Wanner C, Wiecek A.

Semin Dial. 2009 Jul-Aug;22(4):323-8. doi: 10.1111/j.1525-139X.2009.00574.x.

PMID:
19708975
43.

Paradoxical role for adiponectin in chronic renal diseases? An example of reverse epidemiology.

Beige J, Heipmann K, Stumvoll M, Körner A, Kratzsch J.

Expert Opin Ther Targets. 2009 Feb;13(2):163-73. doi: 10.1517/14728220802658481 . Review.

PMID:
19236235
44.

CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine.

Kreutz R, Bolbrinker J, van der Sman-de Beer F, Boeschoten EW, Dekker FW, Kain S, Martus P, Sietmann A, Friedrichs F, Stoll M, Offermann G, Beige J.

Pharmacogenomics J. 2008 Dec;8(6):416-22. doi: 10.1038/sj.tpj.6500488. Epub 2008 Jan 8.

PMID:
18180803
45.

[Acute renal failure: pathophysiology and clinical management].

Beige J, Kreutz R, Rothermund L.

Dtsch Med Wochenschr. 2007 Nov;132(48):2569-78. Review. German.

PMID:
18033653
46.

[Hyperparathyroidism--new aspects].

Kruse A, Beige J.

Ther Umsch. 2007 May;64(5):265-9. Review. German.

PMID:
17685085
47.

[Polyuria].

Treutler T, Ruf B, Beige J.

Ther Umsch. 2006 Sep;63(9):615-8. Review. German.

PMID:
17048178
48.

Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome.

Westhoff TH, Schmidt S, Zidek W, Beige J, van der Giet M.

Clin Nephrol. 2006 Jun;65(6):393-400.

PMID:
16792133
49.

Ethnic origin determines the impact of genetic variants in dopamine receptor gene (DRD1) concerning essential hypertension.

Beige J, Bellmann A, Sharma AM, Gessner R.

Am J Hypertens. 2004 Dec;17(12 Pt 1):1184-7.

PMID:
15607627
50.

The effect of variable CYP3A5 expression on cyclosporine dosing, blood pressure and long-term graft survival in renal transplant patients.

Kreutz R, Zürcher H, Kain S, Martus P, Offermann G, Beige J.

Pharmacogenetics. 2004 Oct;14(10):665-71.

PMID:
15454731

Supplemental Content

Support Center